Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Micron Technology has shed about 1.8% this week, a modest pullback after a 3% pop on its Q4 fiscal 2026 earnings result, and the more interesting story now is the divergence between a stock trading at $1,045 and a Street that has spent the past week raising targets aggressively above that level.
The analyst reaction to the print has been uniformly constructive, and the target-raising has been broad rather than narrow. DA Davidson's Gil Luria moved his target from $2,100 to $3,000 in the session following the note published here yesterday, a 43% lift that puts him at the top of the range. Mizuho and Rosenblatt both raised targets after the result, to $1,400 and $1,900 respectively, while Morgan Stanley reiterated Overweight with a $1,200 target. The consensus mean now sits at $1,555, roughly 49% above the current price. That kind of gap reflects the bull case directly: F4Q26 revenue hit $54.2 billion, up 379% year over year, F1Q27 guidance points to $60 billion to $63 billion, and management is framing supply as tight through 2027 and 2028. Bears counter that cost inflation is real, with DRAM and NAND costs guided up 16% and 19% quarter over quarter, that geopolitical risk across multiple Asian manufacturing hubs is structural, and that HBM share loss to Samsung and SK Hynix remains a genuine threat to the AI-driven margin story.
Valuation multiples have moved sharply in the right direction for bulls. The trailing PE multiple has contracted roughly 14% over the past 30 days even as the stock has gained 2.8% over the same window, which means earnings estimates have risen faster than price. EV/EBITDA has similarly compressed, down about 16% over 30 days. At roughly 5.2x trailing earnings and 4.0x EV/EBITDA, the multiples look unusually low for a company posting these growth rates, though the bear case would note that memory cycles make trailing multiples a poor guide at peaks. EPS momentum ranks in the 97th percentile on a 30-day basis and 96th over 90 days, a near-record revision pace.
Positioning in the lending market is effectively a non-story at this point, which is itself informative. Short interest has continued to drift lower, falling a further 3.4% on the week to 2.38% of free float, a continuation of the cover-before-print trend documented in earlier notes. Availability is unlimited: roughly 1.1 billion shares are available to borrow against a short position of around 26.7 million. Cost to borrow is 0.30%, negligible. The put/call ratio at 1.02 is now running slightly below its 20-day average of 1.05, a z-score of negative 0.92, meaning options traders have moved marginally less defensive than their recent norm. There is no squeeze setup here and no sign of renewed short conviction.
The institutional register shows the big passive and active managers adding steadily. BlackRock holds 9.3% and added 1.7 million shares in the period to September 30. JP Morgan Asset Management made the most aggressive move of the visible holders, adding 8 million shares to bring its position to 1.6% of the company. T. Rowe Price added 9.3 million shares in a single filing period, the largest single-holder build in the register. Capital World Investors is the one name going the other way, having cut its disclosed stake from 5.2% to 3.7% in a filing dated May 2026, though under 13D/G rules that position is as-last-disclosed and may have moved further since.
The next earnings date is December 16. Between now and then, what matters most is whether the memory pricing narrative holds as cost inflation flows through the income statement, and whether early HBM data points corroborate or challenge management's confidence that supply constraints remain Micron's friend rather than a risk to unwind.
See the live data behind this article on ORTEX.
Open MU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
